Search Within

Early Drug Development Service

Formats
  1. Meeting Abstract (236)
  2. Journal Article (210)
  3. Review (7)
  4. Editorial (5)
  5. Research Letter (3)
  6. Miscellaneous (2)
  7. Book Section (1)
Groups
  1. Department of Medicine (464)
  2. Solid Tumor Oncology Division (464)
  3. GSK Faculty (245)
  4. Department of Pathology and Laboratory Medicine (201)
  5. Human Oncology and Pathogenesis Program (194)
  6. Gynecologic Medicine Service (188)

More Groups

People
  1. David Hyman (354)
  2. Alison Schram (125)
  3. Alexander Drilon (112)
  4. Michael Berger (111)
  5. David Solit (110)
  6. Marc Ladanyi (91)

More People

Years
  1. 2025 (9)
  2. 2024 (29)
  3. 2023 (18)
  4. 2022 (27)
  5. 2021 (27)
  6. 2020 (49)

More Years

Publications
  1. Journal of Clinical Oncology (113)
  2. Annals of Oncology (38)
  3. Cancer Research (37)
  4. Clinical Cancer Research (33)
  5. Cancer Discovery (23)
  6. Blood (21)

More Publications

Publishers
  1. American Society of Clinical Oncology (128)
  2. American Association for Cancer Research (101)
  3. Oxford University Press (45)
  4. Elsevier Inc. (34)
  5. Nature Publishing Group (29)
  6. American Society of Hematology (23)

More Publishers

Results (464)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers
    Journal Article

    Hyman, D. M.; Zhou, Q.; Arnold, A. G.; Grisham, R. N.; Iasonos, A.; Kauff, N. D.; Spriggs, D.
    Gynecologic Oncology (2011)

    Fulltext@MSK | Save
  • Prostate cancer with disseminated intravascular coagulation and excessive fibrinolysis (DIC XFL)
    Meeting Abstract

    Hyman, D. M.; Scher, H. I.; Kampel, L. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A germline JAK2 SNP is associated with predisposition to the development of JAK2 V617f-positive myeloproliferative neoplasms
    Meeting Abstract

    Kilpivaara, O.; Mukherjee, S.; Schram, A.; Wadleigh, M.; Mullally, A.; Ebert, R.; Bass, A.; Marubayashi, S.; Heguy, A.; Garcia-Manero, G.; more...
    Haematologica (2009)

    Fulltext@MSK | Save
  • A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms
    Journal Article

    Kilpivaara, O.; Mukherjee, S.; Schram, A. M.; Wadleigh, M.; Mullally, A.; Ebert, B. L.; Bass, A.; Marubayashi, S.; Heguy, A.; Garcia-Manero, G.; more...
    Nature Genetics (2009)

    Fulltext@MSK | Save